S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
TSE:BLU

BELLUS Health News Headlines

C$4.85
-0.11 (-2.22 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
C$4.52
Now: C$4.85
C$4.97
50-Day Range
C$4.00
MA: C$4.83
C$5.74
52-Week Range
C$2.70
Now: C$4.85
C$16.68
Volume538,794 shs
Average Volume341,647 shs
Market CapitalizationC$379.93 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

BELLUS Health (TSE BLU) News Headlines Today

Source:
SourceHeadline
BELLUS Health (TSE:BLU) Shares Cross Above Fifty Day Moving Average of $4.73BELLUS Health (TSE:BLU) Shares Cross Above Fifty Day Moving Average of $4.73
americanbankingnews.com - February 27 at 4:30 AM
BELLUS Health Reports Year 2020 Financial Results and Business HighlightsBELLUS Health Reports Year 2020 Financial Results and Business Highlights
finance.yahoo.com - February 25 at 6:41 PM
BELLUS Health shares are trading higher as traders circulate a TipRanks article mentioning the stock.BELLUS Health shares are trading higher as traders circulate a TipRanks article mentioning the stock.
benzinga.com - February 20 at 9:23 AM
BELLUS Health (TSE:BLU) Shares Cross Above 50-Day Moving Average of $4.50BELLUS Health (TSE:BLU) Shares Cross Above 50-Day Moving Average of $4.50
americanbankingnews.com - February 19 at 3:36 AM
Will Bellus Health (BLU) Report Negative Q4 Earnings? What You Should KnowWill Bellus Health (BLU) Report Negative Q4 Earnings? What You Should Know
msn.com - February 18 at 2:19 PM
BELLUS Health (TSE:BLU) Stock Price Passes Above Fifty Day Moving Average of $4.36BELLUS Health (TSE:BLU) Stock Price Passes Above Fifty Day Moving Average of $4.36
americanbankingnews.com - February 11 at 4:46 AM
What Are Good Penny Stocks To Watch Before 2021? 3 Names To KnowWhat Are Good Penny Stocks To Watch Before 2021? 3 Names To Know
marketwatch.com - December 7 at 4:04 PM
BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx ConferenceBELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference
finance.yahoo.com - November 24 at 8:28 AM
The President of BELLUS Health Inc. (TSE:BLU), Roberto Bellini, Just Bought 7.2% More SharesThe President of BELLUS Health Inc. (TSE:BLU), Roberto Bellini, Just Bought 7.2% More Shares
finance.yahoo.com - October 23 at 9:23 AM
BELLUS Health prices $35M public offering in Canada and USBELLUS Health prices $35M public offering in Canada and US
seekingalpha.com - October 20 at 8:46 AM
Is BELLUS Health Inc. (TSE:BLU) Popular Amongst Institutions?Is BELLUS Health Inc. (TSE:BLU) Popular Amongst Institutions?
finance.yahoo.com - September 7 at 9:17 AM
LD Micro 360 Companies Set to Present this WeekLD Micro 360 Companies Set to Present this Week
finance.yahoo.com - August 31 at 5:22 PM
BELLUS Health Reports Second Quarter 2020 Financial Results and Business HighlightsBELLUS Health Reports Second Quarter 2020 Financial Results and Business Highlights
finance.yahoo.com - August 13 at 7:19 AM
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against BELLUS Health Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against BELLUS Health Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
finance.yahoo.com - July 9 at 6:48 PM
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies BELLUS Health (BLU) Investors of Ongoing Investigation of Possible Securities Fraud, Encourages Investors and Persons Who May be Able to Assist Investigation to Contact the FirmHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies BELLUS Health (BLU) Investors of Ongoing Investigation of Possible Securities Fraud, Encourages Investors and Persons Who May be Able to Assist Investigation to Contact the Firm
finance.yahoo.com - July 9 at 6:48 PM
BRIEF-Bellus Health Announces Topline Results From Phase 2 Relief Trial Of Blu-5937 For Treatment Of Refractory Chronic CoughBRIEF-Bellus Health Announces Topline Results From Phase 2 Relief Trial Of Blu-5937 For Treatment Of Refractory Chronic Cough
www.reuters.com - July 6 at 9:25 PM
Bellus stock drops 72% after highly anticipated drug disappoints in human trialsBellus stock drops 72% after highly anticipated drug disappoints in human trials
www.theglobeandmail.com - July 6 at 9:25 PM
Why Bellus Health Stock Tanked 69.2% TodayWhy Bellus Health Stock Tanked 69.2% Today
finance.yahoo.com - July 6 at 4:24 PM
BLU, ATHE among premarket losersBLU, ATHE among premarket losers
seekingalpha.com - July 6 at 11:24 AM
Thinking about buying stock in Nokia, Royal Caribbean Cruises, Workhorse Group, TAL Education Group, or BELLUS Health?Thinking about buying stock in Nokia, Royal Caribbean Cruises, Workhorse Group, TAL Education Group, or BELLUS Health?
www.marketwatch.com - July 6 at 11:24 AM
Bellus Health lead drug flunks chronic cough studyBellus Health lead drug flunks chronic cough study
seekingalpha.com - July 6 at 11:24 AM
BELLUS Health: BLU-5937 RELIEF Trial Did Not Achieve Statistical Significance For Primary GoalBELLUS Health: BLU-5937 RELIEF Trial Did Not Achieve Statistical Significance For Primary Goal
www.nasdaq.com - July 6 at 11:24 AM
BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment and the BLU-5937 ProgramBELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment and the BLU-5937 Program
finance.yahoo.com - May 13 at 9:37 AM
BELLUS Health's Shares March Higher, Can It Continue?BELLUS Health's Shares March Higher, Can It Continue?
finance.yahoo.com - May 13 at 9:37 AM
Analysts Estimate Bellus Health (BLU) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Bellus Health (BLU) to Report a Decline in Earnings: What to Look Out for
www.nasdaq.com - May 6 at 3:10 PM
BELLUS Health Announces Change to Annual and Special Shareholder Meeting FormatBELLUS Health Announces Change to Annual and Special Shareholder Meeting Format
finance.yahoo.com - May 5 at 5:16 PM
BELLUS Health Announces Completion of Dosing in Phase 2 RELIEF Trial with BLU-5937 for the Treatment of Refractory Chronic CoughBELLUS Health Announces Completion of Dosing in Phase 2 RELIEF Trial with BLU-5937 for the Treatment of Refractory Chronic Cough
finance.yahoo.com - April 6 at 9:47 PM
BELLUS Health Announces Closing of Transaction to Acquire Remaining Intellectual Property Rights to BLU-5937 from adMare BioInnovationsBELLUS Health Announces Closing of Transaction to Acquire Remaining Intellectual Property Rights to BLU-5937 from adMare BioInnovations
finance.yahoo.com - March 25 at 2:23 PM
BRIEF-Bellus Health Inc - Bellus To Own 100% Of BLU-5937 And Related P2X3 Antagonists Intellectual Property With No Future Payments DueBRIEF-Bellus Health Inc - Bellus To Own 100% Of BLU-5937 And Related P2X3 Antagonists Intellectual Property With No Future Payments Due
www.reuters.com - March 23 at 8:35 AM
BELLUS Health Announces Transaction to Acquire Remaining Intellectual Property Rights to BLU-5937 from adMare BioInnovationsBELLUS Health Announces Transaction to Acquire Remaining Intellectual Property Rights to BLU-5937 from adMare BioInnovations
finance.yahoo.com - March 23 at 8:35 AM
BRIEF-Bellus Health Says Completed Enrollment In Phase 2 Relief Trial Of Blu-5937 For Refractory Chronic CoughBRIEF-Bellus Health Says Completed Enrollment In Phase 2 Relief Trial Of Blu-5937 For Refractory Chronic Cough
www.reuters.com - March 19 at 11:11 PM
IIROC Trading Halt - BLUIIROC Trading Halt - BLU
finance.yahoo.com - March 19 at 1:10 PM
IIROC Trade Resumption - BLUIIROC Trade Resumption - BLU
finance.yahoo.com - March 19 at 1:10 PM
Bellus Health completes enrollment in mid-stage BLU-5937 trialBellus Health completes enrollment in mid-stage BLU-5937 trial
seekingalpha.com - March 19 at 8:09 AM
BELLUS Health Announces Completion of Enrollment in Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic CoughBELLUS Health Announces Completion of Enrollment in Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
finance.yahoo.com - March 19 at 8:09 AM
Have Insiders Been Buying BELLUS Health Inc. (TSE:BLU) Shares This Year?Have Insiders Been Buying BELLUS Health Inc. (TSE:BLU) Shares This Year?
finance.yahoo.com - February 21 at 7:16 AM
BELLUS Health Inc.BELLUS Health Inc.
www.barrons.com - February 15 at 10:40 PM
Should You Worry About BELLUS Health Inc.'s (TSE:BLU) CEO Salary Level?Should You Worry About BELLUS Health Inc.'s (TSE:BLU) CEO Salary Level?
finance.yahoo.com - January 16 at 8:55 AM
Hedge Funds Welcomed BELLUS Health Inc. (BLU) With Open ArmsHedge Funds Welcomed BELLUS Health Inc. (BLU) With Open Arms
finance.yahoo.com - December 13 at 1:55 PM
Does BELLUS Health Inc. (TSE:BLU) Have A Particularly Volatile Share Price?Does BELLUS Health Inc. (TSE:BLU) Have A Particularly Volatile Share Price?
finance.yahoo.com - September 19 at 4:51 PM
BELLUS Health Announces Exercise of Over-Allotment Option in Connection With Underwritten Public Offering of Common SharesBELLUS Health Announces Exercise of Over-Allotment Option in Connection With Underwritten Public Offering of Common Shares
finance.yahoo.com - September 18 at 7:29 AM
Buy Bellus Health Before It Hits The NasdaqBuy Bellus Health Before It Hits The Nasdaq
seekingalpha.com - September 15 at 5:19 PM
Birch Pollen Allergy Drug Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2025Birch Pollen Allergy Drug Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2025
www.marketwatch.com - September 11 at 8:36 AM
BELLUS Health Closes US$70 Million Public Offering of Common Shares in Canada and the United StatesBELLUS Health Closes US$70 Million Public Offering of Common Shares in Canada and the United States
finance.yahoo.com - September 9 at 12:48 PM
US IPO Weekly Recap: The fall IPO market is looking up as 10 companies launch in a 1-IPO weekUS IPO Weekly Recap: The fall IPO market is looking up as 10 companies launch in a 1-IPO week
www.nasdaq.com - September 6 at 11:18 PM
BELLUS Health Seeks $60 Million U.S. IPOBELLUS Health Seeks $60 Million U.S. IPO
seekingalpha.com - September 5 at 9:24 AM
Canadian biotech BELLUS Health prices upsized $70 million US IPO at $7.10Canadian biotech BELLUS Health prices upsized $70 million US IPO at $7.10
www.nasdaq.com - September 5 at 9:24 AM
BRIEF-BELLUS Health Announces The Launch Of A $60 Mln Public Offering Of Common Shares In Canada And U.S.BRIEF-BELLUS Health Announces The Launch Of A $60 Mln Public Offering Of Common Shares In Canada And U.S.
www.msn.com - September 3 at 9:42 PM
BELLUS Health Strengthens Leadership Team with Appointment of Dr. Catherine Bonuccelli, MD as Chief Medical OfficerBELLUS Health Strengthens Leadership Team with Appointment of Dr. Catherine Bonuccelli, MD as Chief Medical Officer
finance.yahoo.com - August 26 at 11:33 AM
Read This Before Selling BELLUS Health Inc. (TSE:BLU) SharesRead This Before Selling BELLUS Health Inc. (TSE:BLU) Shares
finance.yahoo.com - August 22 at 9:59 AM
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.